SEC Form 4 · accession 0000899243-17-018665
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David L Mahoney
Director
Period of report
Jul 18, 2017
Accepted (ET)
Jul 20, 2017 · 9:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 18, 2017 | M | 6,091 | $2.23 | A | 1,141,764 | I | Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust |
| Common StockF2 | Jul 18, 2017 | S | 6,091 | $12.5002 | D | 1,135,673 | I | Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust |
| Common Stock | Jul 19, 2017 | M | 16,915 | $2.23 | A | 1,152,588 | I | Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust |
| Common StockF2 | Jul 19, 2017 | S | 16,915 | $12.5012 | D | 1,135,673 | I | Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $2.23 | Jul 18, 2017 | M | 6,091 | D | — | Jun 9, 2018 | Common Stock | 6,091 | 16,915 | D |
| Stock Option (Right to Buy)F3 | $2.23 | Jul 19, 2017 | M | 16,915 | D | — | Jun 9, 2018 | Common Stock | 16,915 | 0 | D |
Explanation of responses
- F1These transactions are made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.
- F2Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $12.50 to $12.505 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- F3Fully exercisable.